Cadence Design Systems vs Change Healthcare vs Chartboost: Which Is Right for You in 2026?

There is no real overlap here — Cadence, Change Healthcare, and Chartboost are large, specialized B2B platforms serving three unrelated industries: chip…

Cadence Design Systems

Enterprise licensing sold via direct sales; pricing is not publicly disclosed · From Custom pricing (contact sales); no self-serve or published tiers

Best for: Semiconductor and systems companies that need EDA software for IC, SoC, or PCB design, evaluated against direct competitors like Synopsys and Siemens EDA.

Change Healthcare

Enterprise / custom quote (B2B healthcare infrastructure, not self-serve SaaS) · From Custom pricing; not publicly listed

Best for: Healthcare payers, providers, and pharmacies that need claims processing and payment connectivity at national scale, now delivered as part of Optum Insight.

Chartboost

Revenue share / programmatic ad platform (not a fixed-fee subscription) · From Free to integrate; monetized via ad revenue share and programmatic bidding

Best for: Mobile game studios that want to monetize inventory through programmatic ad auctions without a fixed subscription fee.

At a Glance

 Cadence Design SystemsChange HealthcareChartboost
Primary categoryCRMCRMCRM
RatingNot documentedNot documentedNot documented
Pricing modelEnterprise licensing sold via direct sales; pricing is not publicly disclosedEnterprise / custom quote (B2B healthcare infrastructure, not self-serve SaaS)Revenue share / programmatic ad platform (not a fixed-fee subscription)
Starting priceCustom pricing (contact sales); no self-serve or published tiersCustom pricing; not publicly listedFree to integrate; monetized via ad revenue share and programmatic bidding
Free planNot documentedNot documentedNot documented
Free trialNot documentedNot documentedNot documented
PlatformsNot documentedNot documentedNot documented
Team collaborationNot documentedNot documentedNot documented
AI featuresNot documentedNot documentedNot documented
Public APINot documentedNot documentedNot documented

Standout Differences

Three unrelated industries, one shared trait: none publish public pricing

Cadence and Change Healthcare are both sold via direct enterprise sales with pricing not publicly disclosed. Chartboost is technically free to integrate, but it monetizes through revenue share and programmatic bidding rather than a fixed subscription — so none of the three give a buyer a straightforward price to compare.

Cadence Design Systems, Change Healthcare, Chartboost

Ownership status varies sharply

Cadence is an independent, publicly traded company (NASDAQ: CDNS) with roughly 13,800 employees. Change Healthcare is now part of Optum Insight within UnitedHealth Group, and Chartboost has changed hands three times — from Zynga (2021) to Take-Two (2022) to adtech company LoopMe (December 2024) — which matters for buyers assessing long-term platform stability.

Cadence Design Systems, Change Healthcare, Chartboost

Change Healthcare's scale is also its risk profile

Change Healthcare processes a large share of US medical claims, which is exactly why the February 2024 ransomware attack on it disrupted healthcare billing nationwide. Buyers evaluating claims infrastructure at this scale need to weigh that concentration risk in a way that doesn't apply to Cadence or Chartboost.

Change Healthcare

Cadence operates in an oligopoly, the other two don't

Cadence competes primarily with Synopsys and Siemens EDA in a market where nearly every major semiconductor company relies on one of a handful of vendors. Change Healthcare and Chartboost operate in markets with different competitive dynamics — healthcare claims infrastructure and mobile ad mediation, respectively.

Cadence Design Systems

Feature-by-Feature

Business Model & Pricing

FeatureCadence Design SystemsChange HealthcareChartboost
Published self-serve pricingUnavailableUnavailableLimited
Revenue-share / programmatic pricing modelUnavailableUnavailableAvailable
Custom, direct enterprise sales contractsAvailableAvailableNot documented

Industry Focus

FeatureCadence Design SystemsChange HealthcareChartboost
Semiconductor / chip and PCB design toolingAvailableUnavailableUnavailable
Healthcare claims and payer-provider-pharmacy connectivityUnavailableAvailableUnavailable
Mobile game ad monetization (DSP/SSP/mediation)UnavailableUnavailableAvailable

Company & Ownership

FeatureCadence Design SystemsChange HealthcareChartboost
Independent, publicly traded companyAvailableUnavailableUnavailable
Recent change of ownership via acquisitionNot documentedAvailableAvailable

Pricing Compared

Starting price reflects the lowest paid tier, not the full cost for every team size or usage level.

Cadence Design Systems

No individual plan breakdown documented yet.

Change Healthcare

No individual plan breakdown documented yet.

Chartboost

No individual plan breakdown documented yet.

Pros & Cons

Cadence Design Systems

Pros

  • Industry-leading depth across the full chip design and verification lifecycle
  • Long, proven track record as core infrastructure for the global semiconductor industry
  • Deep partnerships with major foundries keep tools current with the latest process nodes
  • Financially stable, publicly reported company with substantial R&D investment
  • Diversification into life sciences computational software reduces reliance on any single market

Cons

  • No public pricing; evaluating cost requires a direct sales engagement
  • Steep learning curve and specialized expertise required, not accessible to casual or non-expert users
  • Effectively a duopoly/oligopoly market with Synopsys, limiting competitive pricing pressure
  • Licensing is typically structured around multi-year commitments rather than flexible short-term use
  • Tools are built for large semiconductor and systems companies, not smaller teams or hobbyist chip designers

Change Healthcare

Pros

  • Extremely deep integration across US payers, providers, and pharmacies, giving broad claims coverage
  • Long operating history (roots back to 2007) with deep domain expertise in healthcare billing
  • Now backed by UnitedHealth Group and Optum's scale and capital resources
  • Wide range of revenue-cycle and interoperability products beyond just claims clearinghouse

Cons

  • Suffered one of the most disruptive healthcare cyberattacks in US history in February 2024, exposing systemic fragility
  • The 2024 breach exposed protected health information, raising lasting privacy and trust concerns
  • Ownership by UnitedHealth/Optum raises antitrust and data-concentration concerns that were litigated by the DOJ
  • Not a self-serve or transparently priced product; access is enterprise-only through negotiated contracts
  • Brand is being absorbed into Optum Insight, making it harder to evaluate as a distinct standalone product

Chartboost

Pros

  • Long track record in mobile game adtech dating back to 2011
  • Combines DSP, SSP, and mediation in one platform rather than requiring separate tools
  • Historically strong scale, with hundreds of millions of monthly active users across its network
  • Backed by larger corporate owners over time (Zynga, Take-Two, now LoopMe), providing resourcing and stability
  • Well-established SDK that many mobile game developers are already familiar with integrating

Cons

  • Ownership has changed three times in under five years (Zynga to Take-Two to LoopMe), creating uncertainty about long-term product direction
  • Facing intense competition from larger, more dominant mediation platforms like AppLovin MAX and Unity LevelPlay
  • Not a transparent, published-pricing product; monetization economics depend on ad market conditions and revenue share
  • Primarily useful to mobile game developers, with limited relevance outside gaming adtech
  • Recent divestitures suggest it was viewed as non-core by its prior corporate parents

Use Cases

Choose Cadence Design Systems: Semiconductor and systems companies that need EDA software for IC, SoC, or PCB design, evaluated against direct competitors like Synopsys and Siemens EDA.
Choose Change Healthcare: Healthcare payers, providers, and pharmacies that need claims processing and payment connectivity at national scale, now delivered as part of Optum Insight.
Choose Chartboost: Mobile game studios that want to monetize inventory through programmatic ad auctions without a fixed subscription fee.

Cadence Design Systems

  • Digital and analog chip design — A semiconductor company uses Cadence's design and implementation tools to build the digital and analog blocks of a new integrated circuit before sending it to a foundry for fabrication.
  • Pre-silicon functional verification — An engineering team uses Cadence's simulation and hardware-assisted emulation systems to validate a chip design's behavior before committing to expensive silicon fabrication.
  • Computational drug discovery — A pharmaceutical research team applies Cadence's molecular modeling and simulation software to accelerate early-stage drug discovery workflows.

Change Healthcare

  • Hospital and health system billing operations — Revenue cycle and claims teams use Change Healthcare's clearinghouse and payment tools to submit claims, verify eligibility, and reconcile payments with insurers.
  • Pharmacy claims adjudication — Retail and specialty pharmacies route prescription claims through Change Healthcare's switch to confirm coverage and process payment with PBMs and insurers at the point of sale.
  • Payer-provider data exchange and interoperability — Health insurers and provider organizations use Change Healthcare (now Optum Insight) infrastructure to exchange administrative and clinical data required for claims and prior authorization.

Chartboost

  • Monetizing free-to-play mobile games — Game developers integrate Chartboost's SDK to serve rewarded video, interstitial, and banner ads and generate revenue from their player base.
  • User acquisition for mobile games — Studios use Chartboost's demand-side platform to bid for ad placements across its publisher network to acquire new players.
  • Brand advertising into mobile app inventory — Under LoopMe ownership, brand advertisers can use Chartboost's supply reach to place campaigns across mobile game inventory.

Frequently Asked Questions

Are Cadence Design Systems, Change Healthcare, and Chartboost competitors?

No. They serve completely different industries — Cadence builds electronic design automation software for chip and PCB design, Change Healthcare provides claims processing and payment connectivity for healthcare payers and providers, and Chartboost is a mobile game advertising and monetization platform. None of them compete for the same buyer.

Which of the three has publicly disclosed pricing?

None of them do in the conventional sense. Cadence and Change Healthcare both sell through direct enterprise sales with pricing not publicly disclosed. Chartboost is free to integrate but earns revenue through ad revenue share and programmatic bidding rather than a fixed subscription fee.

Is Change Healthcare still an independent company?

No. Change Healthcare now operates as part of Optum Insight within UnitedHealth Group. It remains a major processor of US medical claims, which is also why its February 2024 ransomware attack had such a wide impact on national healthcare billing.

Who owns Chartboost today?

Chartboost is owned by adtech company LoopMe as of December 2024. Before that it passed through Zynga, which acquired it in 2021, and then Take-Two Interactive, which took ownership when it bought Zynga in 2022.

How would a buyer actually choose between these three?

In practice they wouldn't choose between them — the decision depends entirely on the industry. A semiconductor company evaluating chip design tools would compare Cadence against Synopsys and Siemens EDA, not against Change Healthcare or Chartboost. A healthcare payer or provider would evaluate Change Healthcare against other claims-processing infrastructure, and a mobile game studio would evaluate Chartboost against other ad mediation platforms.

Read the full Cadence Design Systems review · Read the full Change Healthcare review · Read the full Chartboost review